1h Free Analyst Time
This report offers market size & forecast data for the US syringes & needles market. The revenue generated from the sale of syringes & needles is included in the report. The cost of drugs, vaccines, and other medications are excluded from the report's scope. This report provides a comprehensive and current market scenario of the US syringes & needles market, including the US syringes & needles market size, anticipated market forecast, relevant market segmentations, and industry trends. Speak directly to the analyst to clarify any post sales queries you may have.
The study considers a detailed scenario of the present US syringes & needles market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.
MARKET INSIGHTS
- In the US, the syringe and needles market was valued at $7.82 billion in 2022 and is expected to reach $10.87 billion by 2028, growing at a CAGR of 5.63%. The demand for syringes and needles market is on the rise due to multiple factors, including an increasing geriatric population, high prevalence of chronic cases, increasing incidence of hospital-acquired infections, increase in vaccination & immunization programs, and increasing adoption of syringes & needles in treating diabetes.
- By Product type, the syringes segment occupied a market share of 66.43% in 2022 and is expected to grow at a CAGR of 5.98% with an absolute growth rate of 41.67% during the forecast period. Factors such as increasing the demand for disposable syringes and a rapid increase in immunization and vaccination programs are expected to drive the segment growth during the forecast period.
- By Patient type, the adults' segment occupied 68.75% of the market share as of 2022 and is expected to reach 70.22% by 2028 with a CAGR of 6.01% and an absolute growth rate of 41.90%. This is due to the rise in the number of chronic diseases in adults and the increasing diabetic population.
- By End-User type, the hospitals segment accounted for 56.95% of the market share in 2022 and is expected to reach 59.20% with an absolute growth rate of 44.42% by 2028. Hospitals are the primary point of contact for any illness & injuries. Hospitals are the major revenue contributors. All hospitals use needles and syringes to withdraw blood or fluid samples and administer drugs or vaccinations.
- BD, ICU Medical, Nipro Corporation, Terumo, and Cardinal Health are the key players in the US syringes and needles market. Major players focus on strategic acquisitions, licensing, and collaboration agreements with emerging players to enter the US syringes & needles market and access commercially launched products.
VENDORS LIST
- BD
- ICU Medical
- Nipro Medical
- Terumo
- Cardinal Health
- Advacare
- Allison Medicals
- Argon Medical Devices
- Aspen Surgical
- ATS Life Sciences
- Baxter
- Codon
- Credence Medsystems
- Dali Medical Devices
- DeRoyal
- Exelint
- Gerreisheimer
- HMD
- Medtronic
- International Medsurg
- MHC Medical
- Nemera
- NovoNordisk
- Teleflex
- Rectractable Technologies
Table of Contents
Chapter - 1: Syringes & Needles Market Overview
Chapter - 2: Syringes & Needles Market
Chapter - 3: Syringes & Needles Market Segmentation Data
Chapter - 4: Syringes & Needles Market Prospects & Opportunities
Chapter - 5: Syringes & Needles Industry Overview
Chapter - 6: Appendix
List of Exhibits
List of Tables
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 89 |
| Published | December 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 7.82 Billion |
| Forecasted Market Value ( USD | $ 10.87 Billion |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | United States |
| No. of Companies Mentioned | 25 |
